Sinoma Science & Technology Co.,Ltd.

SZSE:002080 Stok Raporu

Piyasa değeri: CN¥21.3b

Sinoma Science & TechnologyLtd Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Sinoma Science & TechnologyLtd has a total shareholder equity of CN¥26.4B and total debt of CN¥17.1B, which brings its debt-to-equity ratio to 64.7%. Its total assets and total liabilities are CN¥58.4B and CN¥31.9B respectively. Sinoma Science & TechnologyLtd's EBIT is CN¥1.2B making its interest coverage ratio 3.1. It has cash and short-term investments of CN¥1.7B.

Anahtar bilgiler

64.7%

Borç/özkaynak oranı

CN¥17.08b

Borç

Faiz karşılama oranı3.1x
NakitCN¥1.67b
EşitlikCN¥26.42b
Toplam yükümlülüklerCN¥31.94b
Toplam varlıklarCN¥58.36b

Son finansal sağlık güncellemeleri

Recent updates

Even With A 44% Surge, Cautious Investors Are Not Rewarding Sinoma Science & Technology Co.,Ltd.'s (SZSE:002080) Performance Completely

Oct 08
Even With A 44% Surge, Cautious Investors Are Not Rewarding Sinoma Science & Technology Co.,Ltd.'s (SZSE:002080) Performance Completely

Should You Investigate Sinoma Science & Technology Co.,Ltd. (SZSE:002080) At CN¥9.99?

Sep 25
Should You Investigate Sinoma Science & Technology Co.,Ltd. (SZSE:002080) At CN¥9.99?

Estimating The Fair Value Of Sinoma Science & Technology Co.,Ltd. (SZSE:002080)

Sep 10
Estimating The Fair Value Of Sinoma Science & Technology Co.,Ltd. (SZSE:002080)

Bearish: Analysts Just Cut Their Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Revenue and EPS estimates

Aug 26
Bearish: Analysts Just Cut Their Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Revenue and EPS estimates

Sinoma Science & TechnologyLtd (SZSE:002080) Might Be Having Difficulty Using Its Capital Effectively

Aug 21
Sinoma Science & TechnologyLtd (SZSE:002080) Might Be Having Difficulty Using Its Capital Effectively

These 4 Measures Indicate That Sinoma Science & TechnologyLtd (SZSE:002080) Is Using Debt Extensively

Jul 25
These 4 Measures Indicate That Sinoma Science & TechnologyLtd (SZSE:002080) Is Using Debt Extensively

Why Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Could Be Worth Watching

Jun 10
Why Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Could Be Worth Watching

Sinoma Science & TechnologyLtd (SZSE:002080) Has Announced That Its Dividend Will Be Reduced To CN¥0.56

May 27
Sinoma Science & TechnologyLtd (SZSE:002080) Has Announced That Its Dividend Will Be Reduced To CN¥0.56

Capital Allocation Trends At Sinoma Science & TechnologyLtd (SZSE:002080) Aren't Ideal

May 13
Capital Allocation Trends At Sinoma Science & TechnologyLtd (SZSE:002080) Aren't Ideal

Are Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Investors Paying Above The Intrinsic Value?

Apr 14
Are Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Investors Paying Above The Intrinsic Value?

Earnings Troubles May Signal Larger Issues for Sinoma Science & TechnologyLtd (SZSE:002080) Shareholders

Mar 31
Earnings Troubles May Signal Larger Issues for Sinoma Science & TechnologyLtd (SZSE:002080) Shareholders

Sinoma Science & Technology Co.,Ltd.'s (SZSE:002080) Price Is Right But Growth Is Lacking

Mar 14
Sinoma Science & Technology Co.,Ltd.'s (SZSE:002080) Price Is Right But Growth Is Lacking

Should You Think About Buying Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Now?

Feb 28
Should You Think About Buying Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Now?

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 002080's short term assets (CN¥19.7B) exceed its short term liabilities (CN¥19.2B).

Uzun Vadeli Yükümlülükler: 002080's short term assets (CN¥19.7B) exceed its long term liabilities (CN¥12.8B).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 002080's net debt to equity ratio (58.3%) is considered high.

Borcun Azaltılması: 002080's debt to equity ratio has reduced from 68.1% to 64.7% over the past 5 years.

Borç Kapsamı: 002080's debt is well covered by operating cash flow (37.7%).

Faiz Kapsamı: 002080's interest payments on its debt are well covered by EBIT (3.1x coverage).


Bilanço


Sağlıklı şirketleri keşfedin